ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-109412

An exposed dangerous endpoint in Ivanti Neurons Patch for Intune allows a remote authenticated attacker to leak sensitive authentication information.

Published Oct 13, 2026 · catalog updated Oct 14, 2026 · An exposed dangerous endpoint

Check if you run it

No confirmed exploitation is on record for CVE-2026-109412. EPSS is 0.87%. Act only if a listed version of An exposed dangerous endpoint is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (An exposed dangerous endpoint).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Critical9.9
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.87%
Remediation
Advisory link
Affected products
See sources for product scope

Serial number: AV26-1035 Date: October 13, 2026 As of October 13, 2026, Ivanti is affected by vulnerabilities in the following products: Ivanti Connect Secure Version 25.1.1.1 and prior Version 25.2.2 and prior Version 22.8R2.4 and prior Ivanti Neurons Patch for Intune Versions prior to September 16, 2026 Ivanti Xtraction Version 2026.2.1 and prior On October 13, 2026, Cybersecurity and Infrastructure Security Agency (CISA) added CVE-2026-104935 to their Known Exploited Vulnerabilities (KEV) Database. The Cyber Centre encourages users and administrators to review the provided web links and app

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2026-109412

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-109412. EPSS is 0.87%. Act only if a listed version of An exposed dangerous endpoint is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-749. EPSS 0.87%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Oct 13, 2026 · NIST NVD

    Detected

    An exposed dangerous endpoint in Ivanti Neurons Patch for Intune allows a remote authenticated attacker to leak sensitive authentication information.

  2. Oct 14, 2026 · NIST NVD

    Updated

    An exposed dangerous endpoint in Ivanti Neurons Patch for Intune allows a remote authenticated attacker to leak sensitive authentication information.

  3. Oct 14, 2026 · NIST NVD

    Updated

    An exposed dangerous endpoint in Ivanti Neurons Patch for Intune allows a remote authenticated attacker to leak sensitive authentication information.

Sources

  • Canadian Centre for Cyber SecurityGovernment advisoryCVE-2026-109412

    Serial number: AV26-1035 Date: October 13, 2026 Updated: October 16, 2026 As of October 13, 2026, Ivanti is affected by vulnerabilities in the following products: Ivanti Connect Secure Version 25.1.1.1 and prior Version 25.2.2 and prior Version 22.8R2.4 and prior Ivanti Neurons P

    cyber.gc.ca
  • CVE.orgVulnerability recordCVE-2026-109412

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-109412

    30-day exploitation probability 0.9%

    first.org
  • NIST NVDVulnerability recordCVE-2026-109412

    An exposed dangerous endpoint in Ivanti Neurons Patch for Intune allows a remote authenticated attacker to leak sensitive authentication information.

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.